Skip to main content
. Author manuscript; available in PMC: 2022 Dec 1.
Published in final edited form as: Prev Med. 2021 Sep 29;153:106820. doi: 10.1016/j.ypmed.2021.106820

Table 5.

Out of pocket costs for dispensed naloxone among the commercially insured population 2015–2018.

Product Year N 25th Pctl ($) 50th Pctl ($) 75th Pctl ($) % $0 OOP % > $100 OOP
All 2015 7229 3.09 12.00 60.00 24 13
2016 36,671 10.00 35.00 75.00 20 16
2017 49,117 8.00 25.00 40.00 21 8
2018 99,917 0.00 24.88 35.69 32 5
EVZIO auto injector 2015 5206 0.00 40.00 100.00 29 19
2016 24,577 25.00 50.00 100.00 18 23
2017 8963 40.00 70.00 130.00 14 29
2018 4990 30.00 70.00 150.00 18 35
Naloxone hydrochloride injection 2015 2023 5.00 10.00 10.00 15 0
2016 4983 5.00 10.00 10.00 20 0
2017 5102 5.00 10.00 10.00 20 0
2018 5459 5.00 10.00 10.00 15 0
Narcan nasal spray 2015 0
2016 7111 0.00 29.80 40.00 26 4
2017 35,052 12.00 25.00 37.34 23 4
2018 89,468 0.00 25.00 35.00 34 4

Notes: Median is reported in dollars, % $0 OOP is the percent of dispensed naloxone in the given category that required zero out of pocket costs, and % > $100 OOP is the percent of dispensed naloxone that required out of pocket costs greater than $100. N is the nationally weighted number of naloxone prescriptions dispensed.